Curaleaf Holdings Inc
Most Recent
Marijuana Legalization Proceeds in Montana amid COVID-19
New Approach Montana resumed its marijuana legalization campaign in May. The group submitted plenty of signatures and qualified for the November ballot.
Haywood Capital Markets Reduced OrganiGram’s Target Price
OrganiGram (NASDAQ:OGI) stock is trading higher before its third-quarter earnings. The stock closed with a gain of 3.9% at $1.58 on Wednesday.
Is Curaleaf a Good Cannabis Pick in 2020?
Curaleaf (OTCMKTS:CURLF) is one of the vertically integrated US cannabis companies. The company has been a top player in the US cannabis space.
Marijuana Legalization Still Has a Chance in Idaho
Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign.
KushCo Holdings Reported Lower Q3 Results, Stock Rose 10%
KushCo Holdings’ third-quarter net revenue was $22.3 million, which was much lower than analysts’ estimate of $31.1 million.
Curaleaf Holdings Completes Curaleaf NJ’s Acquisition
Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.
What to Expect from KushCo Holdings’ Q3 Earnings
KushCo Holdings will likely report its third-quarter results on Wednesday. The company will have an earnings call before the market opens.
OrganiGram Lays Off 220 Employees, Delays Q3 Earnings
To survive amid the current COVID-19 crisis, OrganiGram (NASDAQ:OGI) announced restructuring changes including a 25% cut in its workforce.
Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand
Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.
Green Thumb Keeps Expanding Its Operations in Las Vegas
On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.
Acreage Holdings Posts Disappointing Results in Q1 2020
Acreage Holdings’ first-quarter pro forma revenue grew 65% YoY (year-over-year) to $37.6 million. The revenue beat analysts’ estimates of $34.9 million.
Canopy Growth Revised Its Agreement with Acreage Holdings
Canopy Growth entered into an agreement with US-based cannabis company Acreage Holdings last year. However, the company announced some changes.
Could Acreage Holdings’ Q1 Earnings Boost Its Stock?
Acreage Holdings (OTCMKTS:ACRGF) will likely report its results for the first quarter of fiscal 2020 on Friday before the market opens.
MedMen’s Medical Marijuana Dispensary License Revoked in Virginia
The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.
U.S. Virgin Islands’ Governor Supports Marijuana Legalization
While most businesses suffered amid COVID-19, marijuana saw a drastic rise in sales. Many states have been rethinking the benefits of marijuana legalization.
Will the Abacus Health Acquisition Benefit Charlotte’s Web?
On June 11, Charlotte’s Web announced that it completed the acquisition of Abacus Health. The company’s performance wasn’t strong in the first quarter.
Curaleaf Expands Select Brand Medical Products in Connecticut
On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.
IIPR Acquires Another Property in Pennsylvania
Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.
Green Thumb Industries Opens Its 46th Retail Store
On Monday, Green Thumb Industries (OTCMKTS:GTBIF) opened a Rise brand store in Chambersburg, Pennsylvania—its 46th store in the US.
Marijuana Legalization Campaign in Arkansas Gets a Boost
US states have been looking at strategies to gather signatures and qualify for the 2020 ballot. The pandemic made gathering signatures a challenge.
Marijuana Legalization: New Mexico Voters Show Support
In the 2020 New Mexico Democratic presidential primaries election on June 2, voters ousted most of the Senate candidates who opposed marijuana legalization.
Bermuda Seeks Public Feedback on Legal Cannabis Market
Bermuda wants to expand its legal cannabis market. The government wants public feedback before the upcoming Bermuda Parliament sessions.
Cresco Labs Receives Ohio Provisional Processing License
Cresco Labs (OTCMKTS:CRLBF) is trading 1.8% higher as of 9:44 AM ET today. The company received a provisional processing license by the state of Ohio.
Marijuana Legalization Attempts in New York amid Protests
George Floyd’s death has led to mass protests in the US. Notably, social injustice was one of the main motives behind legalizing marijuana.
Cresco Labs: Analysts Revise 2020 Estimates after Earnings
Cresco Labs (OTCMKTS:CRLBF) is one of the US cannabis companies that has been consistently performing well despite the marijuana industry’s struggles.
MedMen Temporarily Closes Stores amid Protests
Amid the protests following George Floyd’s death in the US, MedMen temporarily closed all of its stores. The stock fell after the news.
Why Green Thumb Industries Is a Good Cannabis Bet
So far in 2020, Green Thumb Industries has returned 6.0%—one of the few cannabis companies with positive returns this year.
Cresco Labs Announces Expansion in Ohio before Q1 Earnings
Cresco Labs (OTCMKTS:CRLBF) will likely report its financial results for the first quarter of fiscal 2020 on May 28 after the market closes.
Will MedMen’s Q3 2020 Earnings Be a Relief?
MedMen Enterprises (OTCMKTS:MMNFF) is scheduled to report its financial results for the third quarter of fiscal 2020 on May 27 after the market closes.
Curaleaf: Analysts’ Recommendations after Its Q1 Earnings
Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.
Marijuana Industry: Opportunities in California amid COVID-19
Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.
Could Certain Marijuana Strains Help Fight COVID-19?
The cannabis industry is doing its own research amid COVID-19. Researchers discovered that marijuana might have properties to fight the coronavirus.
Marijuana Legalization: Democrats and Republicans’ Opposing Views
Democrats and Republicans have always had opposing views about marijuana legalization. Republicans could gain voters if they support legalization.
Canopy Growth: New Cannabis 2.0 Products amid COVID-19
Canopy Growth (NYSE:CGC)(TSE:WEED) still has investors’ attention despite all that the marijuana industry has gone through.
Why Did Curaleaf Report a Mixed Q1 Performance?
On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.
Green Thumb Industries Had a Good Start to Fiscal 2020
Green Thumb Industries reported impressive results for the first quarter of fiscal 2020 on Thursday after the market closed.
Could Marijuana Legalization Help Texas Recover Its Losses?
Texas has suffered huge economic losses. Many industry experts think that marijuana legalization could be a good option to revive the state’s economy.
Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings
Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.
Charlotte’s Web Reports Mixed Q1 Performance
Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.
Why Analysts Are Bullish before Charlotte’s Web’s Q1 Earnings
Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.
IIPR Stock Falls after Reporting Weak Q1 Performance
On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.
Should You Buy IIPR before Its Q1 Earnings?
IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?
Marijuana Legalization Sees Daylight in Lebanon, US Still Waits
Amid COVID-19, people rushed to stock up on marijuana. Lebanon is the first Middle East country to legalize medical marijuana amid the pandemic.
Cresco Labs’ Q4 Earnings: Pleasant Surprise amid COVID-19
Cresco Labs reported its results for the fourth quarter of fiscal 2019 on April 27. Analysts were hopeful about the company’s fourth-quarter earnings.
Why Is There Optimism before Cresco Labs’ Q4 Earnings?
Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.
What to Expect from Cronos Group’s Q4 Earnings Today
Cronos Group will report its fourth-quarter and fiscal 2019 results after the market closes today—a delay from the original date of February 27.
Analysts’ Recommendations after Charlotte’s Web’s Q4 Earnings
Charlotte’s Web Holdings reported its fourth-quarter earnings on March 24. For the quarter, the company missed analysts’ revenue and EBITDA estimates.
Analysts Cut Curaleaf’s Target Price after Its Q4 Earnings
Since Curaleaf reported its fourth-quarter earnings on March 24, Alliance Global Partners and Canaccord Genuity have lowered their target prices.
Arizona Continues Marijuana Legalization Plans in 2020
Marijuana activists in Arizona started the “Smart & Safe Arizona Initiative” as a ballot measure for 2020. The group gathered enough signatures.
3 Cannabis Stocks Investors Should Watch as Markets Rebound
As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.
COVID-19 Pandemic Made Marijuana an Essential Item
Amid the coronavirus pandemic, marijuana has become an essential item in many US states. As a result, there was a surge in cannabis demand.
Curaleaf Reports Impressive Q4 Earnings Results
On Tuesday, Curaleaf (OTCMKTS:CURLF) reported its fourth-quarter earnings after the market closed. The company reported revenue of $75.46 million.
Charlotte’s Web Stock Rose after Its Q4 Earnings
Today, Charlotte’s Web Holdings (TSE:CWEB)(OTCMKTS:CWBHF) reported its fourth-quarter earnings. For the quarter, the company reported revenues of $22.8 million.
Will Curaleaf Beat Analysts’ Expectations in Q4?
Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.
Cannabis Industry Awaits FDA’s Approval for CBD Products
The FDA doesn’t allow CBD products to be used as a food derivative. The agency has been hesitant about how some cannabis companies market CBD products.
What to Expect from Charlotte’s Web’s Q4 Earnings
Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.
Roth Capital Initiates Coverage on IIPR with a ‘Buy’ Rating
On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.
What Do Analysts Recommend for Supreme Cannabis?
Wall Street favors a “hold” rating for Supreme Cannabis. Four analysts recommend a ‘hold,’ three recommend a ‘buy,’ and one recommends a ‘sell.’
Charlotte’s Web Reports Improved Yield and CBD Potency
On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.
What Do Analysts Recommend for Green Growth Brands?
After Green Growth Brands reported its earnings, Eight Capital downgraded the stock from “buy” to “sell.” Currently, three analysts follow the company.
How Will Curaleaf Benefit from Acquiring BlueKudu?
On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.
Analysts Cut GW Pharmaceuticals’s Target Price after Q4 Earnings
On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings. The company reported revenue of $109.1 million, which beat analysts’ expectations.
What Can You Expect from IIPR’s Q4 Earnings?
IIPR will report its results for the fourth quarter of 2019 today after the market closes. Analysts expect the company to post revenue and EPS growth.
Analyzing GW Pharmaceuticals’ Q4 Earnings and Outlook
On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings after the market closed. For the quarter, the company reported revenue of $109.1 million.
Green Growth Brands Reported Mixed Q2 Performance
On Monday, Green Growth Brands reported its earnings results for the second quarter of fiscal 2020. The company reported revenues of $21.1 million.
What to Expect from Green Growth Brands’ Q2 Earnings?
Green Growth Brands will likely report its results for the second quarter of fiscal 2020 on February 24. Analysts expect the company’s revenue to rise sequentially.
Trump Denies Protection to State Medical Marijuana Programs
President Trump introduced a proposal to end an existing policy introduced by Congress. The proposal will be part of the fiscal 2021 budget plan.
Beacon Securities Is Still Bullish on Curaleaf
After Curaleaf completed the acquisition of the Select brand, Russell Stanley of Beacon Securities reiterated his “buy” rating.
IIPR Enters a Long-Term Agreement with GTI
Yesterday, IIPR announced that it bought a licensed cannabis processing facility in Toledo, Ohio, from Green Thumb Industries for $2.9 million.
Cresco Labs Stock Rose after Securing $100 Million Loan
On Thursday, Cresco Labs announced that it signed an agreement for a senior secured term loan for an initial aggregate principal amount of $100 million.
Is Cresco Labs a Good Bet in January?
Analysts expect Cresco Labs to report revenues of $45.3 million in the fourth quarter to take the total revenue for 2019 to $131.9 million.
Why Beacon Securities Is Bullish on Curaleaf
On Monday, Russell Stanley of Beacon Securities reiterated his “buy” rating for Curaleaf Holdings. He gave a target price of 25 Canadian dollars.
Is Charlotte’s Web Still a Good Buy?
Although 2019 was tough for Charlotte’s Web Holdings, it has made a significant recovery this year. The stock has increased by 14.8% YTD as of Monday.
Can Curaleaf Maintain Its Upward Momentum?
Acquisitions could boost Curaleaf’s production and retail footprint significantly. With the EBITDA expected to rise over the next two years, there’s significant upside.
Does 2020 Look Bright for Cannabis in Florida?
There was hope that cannabis legalization would see daylight in Florida in 2020. However, the state faces some hurdles.
What Do Analysts Recommend for KushCo Holdings?
KushCo Holdings reported its Q1 earnings on January 8. KushCo reported revenue of $34.96 million, below analysts’ forecast of $41.5 million.
Stifel Gets Bullish on the Cannabis Sector in 2020
According to a report by Barron’s on January 7, Stifel analysts expect a rebound in the cannabis sector in the first half of 2020.
OrganiGram’s First-Quarter Earnings: What to Expect
Yesterday, OrganiGram stock was trading at 2.68 Canadian dollars, 23.4% lower than when the company reported its fourth-quarter earnings on November 25.
Cannabis Sector Marks Third Straight Day of Decline
The downward momentum in cannabis stocks has continued today, marking the third straight day of decline for the cannabis sector.
‘Make It Legal Florida’ Cannabis Campaign’s Next Step
Florida’s “Make It Legal Florida” measure could push other states to look at cannabis legalization. However, President Trump doesn’t seem supportive.
Why Cannabis Stocks Were Trading Lower Today
On the back of the weakness in the broader equity market, the cannabis sector traded in the red today. At 1:28 PM ET, the S&P 500 Index was down by 0.4%.
Illinois Wakes Up to Legalized Recreational Cannabis
On June 25, Illinois governor J.B. Pritzker signed a bill approving marijuana use for everyone over 21 years old. The law became effective on January 1.
What Analysts Think About Curaleaf in Fiscal 2020
Curaleaf (CURLF) seems to be in a good position in 2019 compared to other cannabis players. Can it keep up its performance in 2020?
Will Santa Claus Rally Boost Cannabis Stocks?
On December 26, a Santa Claus rally seems to be in full swing. This effect pushed the S&P 500 (SPX) and Nasdaq Composite Index (COMP) to record highs.
Major Institutional Investors Still in Cannabis Sector
It seems that despite the tough market conditions, institutional investors are still keen to invest in the cannabis sector.
Cannabis Analyst Believes Curaleaf Still Has Room to Grow
Beacon Securities analyst Russell Stanley expects Curaleaf stock to grow 255% in the next 12 months. Stanley gave a target price of 25 Canadian dollars.
What’s Driving Cannabis Stocks Today?
Boosted by the strong performance from the broader equity market, the cannabis sector was trading in the green today.
Guides A Curaleaf Overview: Origins, Products, and More
Curaleaf Holdings (CURLF) (CURA) is one of the leading vertically integrated cannabis players in the US. The company has operations in 12 states.
Cannabis Sector 2019 Review and 2020 Outlook
Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.
Is Curaleaf a Good Buy in December?
Curaleaf stock is up year-to-date by 16.67%, but is down 9.19% from $6.09 on November 29 to $5.53 on December 16. Is it a good buy in December?
Why MedMen Stock Rose More than 24% on Thursday
The optimistic guidance and initiatives helped MedMen stock rise. On Thursday, the stock closed the day at 0.71 Canadian dollars.
Supreme Cannabis: Lower Target Price after Q1 Earnings
Following Supreme Cannabis’s weak first-quarter performance, PI Financial and Canaccord Genuity lowered their target prices.
A Deep Dive into the Top Cannabis Retailers in Florida
Since Florida legalized medical marijuana, business is booming. In September, the state had 22 licensed vertically integrated medical cannabis operators.
Cannabis Investing in 2019: A Year of Big Reversals
The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.
MedMen: Price Targets and Ratings after Q1 Earnings
There have been no rating changes since MedMen reported its Q1 earnings. Six of eight analysts gave the stock a “hold” rating.
Cannabis Stocks Up despite Weak Equity Market
Despite the weakness in the broader US equity market today, the cannabis sector is trading in the green. Let’s see who’s making big moves today.
Charlotte’s Web Lawsuit: How Can It Impact Investors?
Charlotte’s Web Holdings (CWEB) (CWBHF) is one of the latest cannabis companies to be served with a class-action lawsuit.
Key Takeaways from MedMen’s First-Quarter Earnings
Cannabis retailer MedMen (MMNFF)(MMEN) reported its first quarter of fiscal 2020 earnings results yesterday. Here’s what you need to know.
Cresco Labs Missed Analysts’ Q3 Estimates
Cresco Labs reported its third-quarter earnings on Tuesday after the market closed. The company missed analysts’ top-line and bottom-line estimates.
Green Growth Brands: Q1 2020 Results Are Out
For the first quarter of 2020 ending in September, Green Growth Brands reported revenues of $12.7 million—an increase of 77% sequentially.